Development of a pharmacist-led drug interaction assessment service for patients with cancer diagnosed with mild to moderate COVID-19 infection requiring outpatient treatment
Journal of Oncology Pharmacy Practice
Published online on February 13, 2026
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionWith the introduction of Paxlovid™ (a combination of nirmatrelvir and ritonavir) in Canada, a clinical gap was identified for patients with cancer. These patients often take multiple medications with complex mechanisms that can interact with ...
IntroductionWith the introduction of Paxlovid™ (a combination of nirmatrelvir and ritonavir) in Canada, a clinical gap was identified for patients with cancer. These patients often take multiple medications with complex mechanisms that can interact with ...